Home > Riviste > Journal of Neurosurgical Sciences > Fascicoli precedenti > Journal of Neurosurgical Sciences 2015 June;59(2) > Journal of Neurosurgical Sciences 2015 June;59(2):157-67

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Per citare questo articolo
Share

 

REVIEWS   

Journal of Neurosurgical Sciences 2015 June;59(2):157-67

Copyright © 2015 EDIZIONI MINERVA MEDICA

lingua: Inglese

Post-stereotactic radiosurgery brain metastases: a review

Fabiano A. J. 1, 2, Qiu J. 3

1 Department of Neurosurgery, Roswell Park Cancer Institute, Buffalo, NY, USA; 2 Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA; 3 Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY, USA


PDF


Stereotactic radiosurgery (SR) is a standard therapy for brain metastases. Radiation necrosis (RN) of the brain is a syndrome of brain coagulative and fibrinoid necrosis and cortical irritation that occurs following radiotherapy. RN following SR peaks in a delayed fashion at 9-12 months postprocedure. Vasogenic cerebral edema secondary to necrosis occurs and can affect surrounding brain function. No definitive non-invasive diagnostic study exists to differentiate post-SR RN from recurrent metastatic tumor. Magnetic resonance (MR) imaging, MR spectroscopy, positron emission tomography, and perfusion-weighted MR imaging have been used to evaluate RN and are discussed. Treatment options for post-SR brain metastases include observation, corticosteroids, pentoxifylline and vitamin E, bevacizumab, radiotherapy, laser-interstitial thermal therapy, and surgical resection.

inizio pagina